Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/280
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Polycyclo ring system having the six-membered hetero ring as one of the cyclos > Pentacyclo ring system having the six-membered hetero ring as one of the cyclos
Description: Subject matter wherein the polycyclo ring system consists of exactly five rings.


Sub-classes under this class:

Class Number Class Name Patents
514/283 Ring nitrogen in the pentacyclo ring system is shared by five-membered cyclo and six-membered cyclo (e.g., vincamine, etc.) 354
514/281 Two of the cyclos share at least three ring members (i.e., bridged) 68


Patents under this class:
1 2 3 4 5

Patent Number Title Of Patent Date Issued
7592350 Polycyclic compounds as potent alpha2-adrenoceptor antagonists Sep. 22, 2009
7541346 Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs Jun. 2, 2009
7531550 Pseudobase benzo[c]phenanthridines with improved efficacy, stability, and safety May. 12, 2009
7517883 Solubilized topoisomerase poisons Apr. 14, 2009
7470703 Yohimbine derivatives and use thereof Dec. 30, 2008
7468366 Cytotoxic agents Dec. 23, 2008
7387790 Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells Jun. 17, 2008
7323449 Thionucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase Jan. 29, 2008
7319105 Cytotoxic agents Jan. 15, 2008
7312228 Cytotoxic indeno and isoindoloisoquinolones Dec. 25, 2007
7276512 Benzo[a]pyrano[3,2-h]acridin-7-one compounds Oct. 2, 2007
7232830 Method for treatment of neurodegenerative diseases and effects of aging Jun. 19, 2007
7220428 Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells May. 22, 2007
7208492 Topoisomerase-targeting agents Apr. 24, 2007
7205312 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines Apr. 17, 2007
7201913 Oral formulations for anti-tumor compounds Apr. 10, 2007
7199130 Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists Apr. 3, 2007
7173041 Polyglutamic acid-camptothecin conjugates and methods of preparation Feb. 6, 2007
7153864 Polyglutamic acid-camptothecin conjugates and methods of preparation Dec. 26, 2006
7151108 [3,4-a:3,4-c]carbazole compounds Dec. 19, 2006
7144891 Benzo[b ]pyrano[3,2- h ]acridin-7-one cinnamate compounds Dec. 5, 2006
7125873 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Oct. 24, 2006
7115619 N.sup.8, N.sup.13 -disubstituted quino[4,3,2-kl]acridinium salts as therapeutic agents Oct. 3, 2006
7105492 Camptothecin derivatives having antitumor activity Sep. 12, 2006
7056929 Benzo[b]pyrano[3,2-h]acridin-7-one compounds Jun. 6, 2006
7049315 Solubilized topoisomerase poisons May. 23, 2006
6992088 Nitro and amino substituted heterocycles as topoisomerase I targeting agents Jan. 31, 2006
6992089 Nitro and amino substituted topoisomerase agents Jan. 31, 2006
6989387 Nitro and amino substituted topoisomerase agents Jan. 24, 2006
6987109 Solubilized topoisomerase poison agents Jan. 17, 2006
6967215 Tetrahydrocarbazoles, a process for the preparation of those compounds, and the use thereof Nov. 22, 2005
6964964 Topoisomerase poison agents Nov. 15, 2005
6946472 Polycyclic compounds exhibiting anti-tumor activities Sep. 20, 2005
6893668 Process for isolation of anticancer agent camptothecin from Nothapodytes foetida May. 17, 2005
6878737 Reversal of multidrug resistance in human colon carcinoma cells Apr. 12, 2005
6875439 Formulation containing amphipathic weak base and/or amphipathic cation and multiple drug resistance inhibitor Apr. 5, 2005
6844353 Fungicidal properties of sampangine and its analogs to agriculturally important fungal plant pathogens Jan. 18, 2005
6740659 Treatment of dyskinesia May. 25, 2004
6706704 Method of inducing opioid analgesia and anesthesia without respiratory suppression Mar. 16, 2004
6699676 Uses of ouabain and ouabain-like molecules in apoptosis related pathologies Mar. 2, 2004
6686388 Regulators of the hedgehog pathway, compositions and uses related thereto Feb. 3, 2004
6680326 Polycyclic compounds Jan. 20, 2004
6656948 Cytotoxic compounds: derivatives of the pyrido[2,3,4-kl]acridine ring system Dec. 2, 2003
6645975 Process for the preparation of dinaposoline Nov. 11, 2003
6642248 Benzo[b]pyrano[3,2-h]acridin-7-one compounds Nov. 4, 2003
6638943 Yohimbine dimers exhibiting binding selectivities for .alpha.2 adrenergic receptors Oct. 28, 2003
6632822 Compounds and therapeutic methods Oct. 14, 2003
6608073 Intranasal codeine for the rapid suppression of cough and rapid relief of pain Aug. 19, 2003
6589939 Camptothecin derivatives having antitumor activity Jul. 8, 2003
6583150 Pharmaceutical composition based on polyaromatic compounds Jun. 24, 2003

1 2 3 4 5


 
 
  Recently Added Patents
Concise dynamic grammars using N-best selection
Process for the preparation of opioid modulators
Format converter for WLAN-UMTS interworking employing UMTS air interface
Air blower
Multi-language support for enterprise identity and access management
Nitroderivatives as drugs for diseases having an inflammatory basis
Laser system
  Randomly Featured Patents
Retaining wall for earth and similar materials
Unsupervised training in natural language call routing
Human weighing scale with impedancemeter
Controlled effective coupling coefficients for film bulk acoustic resonators
Method and apparatus to transfer data and detect weak signals
Electronic sunglasses
Wear-resistant alloys particularly suited to aluminum-engine head-valve seats
Methods for transforming plants to express Cry2Ab .delta.-endotoxins targeted to the plastids
Impatiens plant named Lanai
Power controller